Age-related changes of VIP, NPY and somatostatin-immunoreactive neurons in the cerebral cortex of aged rats. (Q48729408)

15 February 2018

title

Age-related changes of VIP, NPY and somatostatin-immunoreactive neurons in the cerebral cortex of aged rats. (English)

1 reference

15 February 2018

author name string

Cha CI

1

1 reference

15 February 2018

Lee YI

2

1 reference

15 February 2018

Lee EY

3

1 reference

15 February 2018

Park KH

4

1 reference

15 February 2018

Baik SH

5

1 reference

15 February 2018

language of work or name

English

0 references

publication date

1 April 1997

1 reference

15 February 2018

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

Brain Research

1 reference

15 February 2018

volume

753

1 reference

15 February 2018

issue

2

1 reference

15 February 2018

page(s)

235-244

1 reference

15 February 2018

Cortical and subcortical neuropeptides in Alzheimer's disease.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Somatostatin and vasoactive intestinal polypeptide in postmortem brains from patients with Alzheimer-type dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Trophic interactions between astroglial cells and hippocampal neurons in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Seven peptides derived from pro-somatostatin in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Cytokine regulation of neuronal survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Cortical neurons immunoreactive with antisera against neuropeptide Y are altered in Alzheimer's-type dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Distribution of altered hippocampal neurons and axons immunoreactive with antisera against neuropeptide Y in Alzheimer's-type dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold/silver intensification on vibratome sections: coexistence with neuropeptide Y neurons, and effects in Alzheimer-type dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Adrenocorticotropin is a specific mitogen for mammalian myogenic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

A quantitative assessment of somatostatin-like and neuropeptide Y-like immunostained cells in the frontal and temporal cortex of patients with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Abnormalities in corticotropin-releasing hormone (CRH) in Alzheimer's disease and other human disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Expression of dopaminergic phenotypes in the mouse olfactory bulb induced by the calcitonin gene-related peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Somatostatin in the central nervous system: physiology and pathological modifications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Neuropeptides in Alzheimer type dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Activation of vasopressinergic and oxytocinergic neurons during aging in the Wistar rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

The vasopressin and oxytocin neurons in the human supraoptic and paraventricular nucleus; changes with aging and in senile dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Brain choline acetyltransferase activity and neuropeptide Y concentrations in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Neuropeptides as growth and differentiation factors in general and VIP in particular

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Vasoactive intestinal peptide gene expression from embryos to aging rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Neuropeptide Y in Relation to Behavior and Psychiatric Disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Vasoactive intestinal peptide antagonist retards the development of neonatal behaviors in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Neuropeptides in aging and dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Striatal neuropeptide Y neurones are under the influence of the nigrostriatal dopaminergic pathway: immunohistochemical evidence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Activation of Vasopressin Neurons in Aging and Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Vasoactive intestinal polypeptide induces glycogenolysis in mouse cortical slices: a possible regulatory mechanism for the local control of energy metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide potentiate c-fos expression induced by glutamate in cultured cortical neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Somatostatin- and neuropeptide Y-immunoreactive neurons in the neocortex in senile dementia of Alzheimer's type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Recombinant cholinergic differentiation factor (leukemia inhibitory factor) regulates sympathetic neuron phenotype by alterations in the size and amounts of neuropeptide mRNAs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Stimulation of connective tissue cell growth by substance P and substance K.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Neuropeptides in Alzheimer's disease, depression and schizophrenia. A post mortem analysis of vasoactive intestinal peptide and cholecystokinin in cerebral cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

II. New evidence for a locus coeruleus-norepinephrine connection with anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Effects of the vagus nerves on gastric motility and release of vasoactive intestinal polypeptide in the anaesthetized lamb.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Glucagon and CCK in human brain: controls and patients with senile dementia of Alzheimer type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Overview: toward a dysregulation hypothesis of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Continuous c-fos expression precedes programmed cell death in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Some morphometric aspects of the brain in senile dementia of the alzheimer type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Neuropeptide Y and somatostatin in the neocortex of young and aging rats: response to nucleus basalis lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

Neurochemical alterations but not nerve cell loss in aged rat neostriatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900009-7

10.1016/S0006-8993(97)00009-7

7 January 2021

Identifiers

DOI

1 reference

15 February 2018

PubMed ID

9125408

1 reference

15 February 2018